385 related articles for article (PubMed ID: 27496705)
1. Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues.
Lundquist P; Artursson P
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):256-276. PubMed ID: 27496705
[TBL] [Abstract][Full Text] [Related]
2. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
3. Intestinal permeation enhancers for oral peptide delivery.
Maher S; Mrsny RJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
[TBL] [Abstract][Full Text] [Related]
4. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
5. Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.
des Rieux A; Fievez V; Momtaz M; Detrembleur C; Alonso-Sande M; Van Gelder J; Cauvin A; Schneider YJ; Préat V
J Control Release; 2007 Apr; 118(3):294-302. PubMed ID: 17292503
[TBL] [Abstract][Full Text] [Related]
6. Models and methods to evaluate transport of drug delivery systems across cellular barriers.
Ghaffarian R; Muro S
J Vis Exp; 2013 Oct; (80):e50638. PubMed ID: 24192611
[TBL] [Abstract][Full Text] [Related]
7. Functional Assessment of Intestinal Tight Junction Barrier and Ion Permeability in Native Tissue by Ussing Chamber Technique.
Hempstock W; Ishizuka N; Hayashi H
J Vis Exp; 2021 May; (171):. PubMed ID: 34125105
[TBL] [Abstract][Full Text] [Related]
8. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
Yamamoto A
Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
[TBL] [Abstract][Full Text] [Related]
9. The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery.
Moss DM; Curley P; Kinvig H; Hoskins C; Owen A
Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):223-236. PubMed ID: 29088978
[TBL] [Abstract][Full Text] [Related]
10. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
11. Oral peptide delivery: Translational challenges due to physiological effects.
Tyagi P; Pechenov S; Anand Subramony J
J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
[TBL] [Abstract][Full Text] [Related]
12. Oral drug delivery with nanoparticles into the gastrointestinal mucosa.
Liu J; Leng P; Liu Y
Fundam Clin Pharmacol; 2021 Feb; 35(1):86-96. PubMed ID: 32749731
[TBL] [Abstract][Full Text] [Related]
13. Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs.
Wils P; Warnery A; Phung-Ba V; Scherman D
Cell Biol Toxicol; 1994 Dec; 10(5-6):393-7. PubMed ID: 7697502
[TBL] [Abstract][Full Text] [Related]
14. Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs.
Liu W; Pan H; Zhang C; Zhao L; Zhao R; Zhu Y; Pan W
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455239
[TBL] [Abstract][Full Text] [Related]
15. Using peptides to increase transport across the intestinal barrier.
Sánchez-Navarro M; Garcia J; Giralt E; Teixidó M
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):355-366. PubMed ID: 27155131
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies.
Rehmani S; Dixon JE
Peptides; 2018 Feb; 100():24-35. PubMed ID: 29412825
[TBL] [Abstract][Full Text] [Related]
17. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
18. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yun Y; Cho YW; Park K
Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
[TBL] [Abstract][Full Text] [Related]
20. Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease.
Mateer SW; Cardona J; Marks E; Goggin BJ; Hua S; Keely S
J Vis Exp; 2016 Feb; (108):e53250. PubMed ID: 26891144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
